VIVANI MEDICAL INC

VANINASDAQ

🏆 #3443 by market capEarnings Aug 12US Equity

$1.41▲ $0.02 (+1.08%)

Live

1h▼ 0.7%

24h▲ 1.1%

7d▲ 3.3%

14d▲ 9.8%

30d▼ 3.1%

1y▲ 11.5%

🏦Market Cap

$121M

Small Cap

📈Revenue Growth (YoY)

+0.0%

Slowing

📊Gross Margin

0.0%

Thin

💵FCF Margin

0.0%

Thin

⚖️P/S Ratio

0.0x

Cheap

Otter Score

Weak

Trading Snapshot

Day Range: $1.39 – $1.41
52-Week Range: $0.92 – $1.92
Volume: $3.82B
Avg Volume: $3.02B
Shares Outstanding: 86.2M
Next Earnings: Sep 2, 2026

Fundamentals Snapshot

Annual Revenue: $20M
Last Q Revenue: $4M
P/E Ratio: -3.5
P/S Ratio: 0.0x
EPS (TTM): $-0.33
Dividend Yield: 0.00%

Why Investors Own VANI

✓High-growth profile — revenue up +36.4% YoY with expanding US Equity exposure.
✓Healthy economics — 26% gross margin and 27% free-cash-flow margin.
✓New products and segments could unlock additional revenue streams.

⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)

$20M▲ +37.2% YoY

Gross Margin (TTM)

25.7%▲ +2.2% YoY

Operating Income (TTM)

$4M▲ +37.2% YoY

Free Cash Flow (TTM)

$5M▲ +37.2% YoY

About VIVANI MEDICAL INC

Vivani Medical, Inc. is a clinical-stage biopharmaceutical company that specializes in developing innovative implantable medical devices. The firm aims to address chronic diseases for which current treatments are insufficient or lacking. Its key initiatives include a portfolio of miniature drug implants, designed to ensure consistent and stable therapeutic drug delivery, as well as advanced implantable visual prostheses intended to provide meaningful artificial vision to blind individuals. Vivani Medical is headquartered in Emeryville, California.

🦦